# Beam Therapeutics Inc.: Form 8-K, filed Feb 24, 2026

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 8-K
- Filed: 2026-02-24
- Accepted by EDGAR: Feb 24, 2026, 12:05 ET
- Period: 2026-02-24
- Accession: 0001193125-26-065191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000119312526065191/beam-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000119312526065191/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000119312526065191/beam-20260224.htm

Filed Feb 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-065191. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.